EUVIMEDEUVIMED entdecken
Crossref

Cyclometalated iridium(III)–robustine coordination compounds as highly potent anticancer agents

Qiu-Ming Li, Xiao-Qiong Huang, Qing Su, Ju-Mei Zhang, Li-Qin Qin, Ming-Xiong Tan, Qi-Pin Qin

Polyhedron · 2025-09 · 279 · 117619

DOI: 10.1016/j.poly.2025.117619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polyhedron, 2025-09. Verfasst von Qiu-Ming Li und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 140 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, Q., Huang, X., Su, Q., Zhang, J., Qin, L., Tan, M., & Qin, Q. (2025). Cyclometalated iridium(III)–robustine coordination compounds as highly potent anticancer agents. Polyhedron, 279, 117619. https://doi.org/10.1016/j.poly.2025.117619

Vancouver

Li Q, Huang X, Su Q, Zhang J, Qin L, Tan M, et al. Cyclometalated iridium(III)–robustine coordination compounds as highly potent anticancer agents. Polyhedron. 2025;279:117619. doi:10.1016/j.poly.2025.117619

BibTeX
@article{Li2025,
  author = {Li, Qiu-Ming and Huang, Xiao-Qiong and Su, Qing and Zhang, Ju-Mei and Qin, Li-Qin and Tan, Ming-Xiong and Qin, Qi-Pin},
  title = {Cyclometalated iridium(III)–robustine coordination compounds as highly potent anticancer agents},
  journal = {Polyhedron},
  year = {2025},
  volume = {279},
  pages = {117619},
  doi = {10.1016/j.poly.2025.117619}
}
Kostenlos starten →